European equities traded in the US as American depositary receipts were falling late Monday morning, dropping 2.31% on the S&P Europe Select ADR Index to 1,411.83.
From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies (DBVT) and petroleum refiner Equinor (EQNR), which rose 6.4% and 5.1%, respectively. They were followed by medical device maker EDAP TMS (EDAP) and consumer goods giant Unilever (UL), which were up 4.8% and 3.1%, respectively.
The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and financial services company Banco Santander (SAN), which fell 10% and 5.7%, respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and internet browser company Opera (OPRA), which were down 5.3% each.
From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and utilities company National Grid (NGG), which advanced 11% and 2.8%, respectively. They were followed by biopharmaceutical company TC Biopharm (TCBP) and oil and gas company BP (BP), which increased 2.3% and 1.4%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Verona Pharma (VRNA) and Akari Therapeutics (AKTX), which lost 7.5% and 7.3%, respectively. They were followed by cruise line operator Carnival (CUK) and financial services company Barclays (BCS), which shed 7.2% each.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。